Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
J Infect Dis ; 208(2): 260-70, 2013 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-23568175

RESUMO

Whether vaccination against a virus can protect against more virulent coinfection with the virus and additional pathogen(s) remains poorly characterized. Overlapping endemicity of human immunodeficiency virus (HIV) and malaria suggests that HIV/malaria coinfection frequently complicates acute and chronic HIV infection. Here we showed that vaccination of macaques with recombinant Listeria ΔactA prfA* expressing simian/human immunodeficiency virus (SHIV) gag and env elicited Gag- and Env-specific T-cell responses, and protected against life-threatening SHIV-related malaria after SHIV/Plasmodium fragile coinfection. SHIV antigen immunization reduced peak viremia, resisted SHIV/malaria-induced lymphoid destruction, and blunted coinfection-accelerated decline of CD4(+) T-cell counts after SHIV/malaria coinfection. SHIV antigen immunization also weakened coinfection-driven overreactive proinflammatory interferon-γ (IFNγ) responses and led to developing T helper cell 17/22 (Th17/Th22) responses after SHIV/malaria coinfection. The findings suggest that vaccination against AIDS virus can alter patterns of immune responses to the SHIV/malaria coinfection and protect against life-threatening SHIV-related malaria.


Assuntos
Antígenos Virais/imunologia , Coinfecção/imunologia , Infecções por HIV/imunologia , Malária/imunologia , Síndrome de Imunodeficiência Adquirida dos Símios/imunologia , Vírus da Imunodeficiência Símia/imunologia , Animais , Linfócitos T CD4-Positivos/imunologia , Coinfecção/microbiologia , Coinfecção/parasitologia , Coinfecção/prevenção & controle , Produtos do Gene env/imunologia , Produtos do Gene gag/imunologia , Infecções por HIV/parasitologia , Infecções por HIV/prevenção & controle , Infecções por HIV/virologia , HIV-1/imunologia , Macaca mulatta/imunologia , Macaca mulatta/microbiologia , Macaca mulatta/virologia , Malária/microbiologia , Malária/prevenção & controle , Plasmodium/imunologia , Síndrome de Imunodeficiência Adquirida dos Símios/prevenção & controle , Síndrome de Imunodeficiência Adquirida dos Símios/virologia , Linfócitos T Auxiliares-Indutores/imunologia , Vacinação/métodos , Vacinas Sintéticas/imunologia
2.
RSC Adv ; 13(28): 19039-19045, 2023 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-37362341

RESUMO

Organic-inorganic hybrid low-dimensional lead halides have garnered significant interest in the realm of solid-state optical materials due to their unique properties and potential applications. In this study, we report the synthesis, characterization and application of Mn2+-doped one-dimensional (1D) [AEP]PbCl5·H2O hybrid lead halide perovskites with tunable photoluminescence properties. The Mn2+ doping leads to a redshift of the dominant emission wavelength from 463 nm to 630 nm, with the optimal doping concentration resulting in an enhanced photoluminescence quantum yield (PLQY) from less than 1% to 8.96%. The structural and optical stability of these doped perovskites have been thoroughly investigated revealing excellent performance under humid and high-temperature conditions. Perovskite-PVP composite films exhibit high crystallization and bright orange-red emission under UV excitation. Furthermore, we demonstrate the successful fabrication of a white LED device using the Mn2+-doped perovskite in combination with commercial green and blue phosphors. The fabricated LED exhibits a high color rendering index (CRI) of 87.2 and stable electroluminescence performance under various operating currents and extended operation times. Our findings highlight the potential of Mn2+-doped 1D hybrid lead halide perovskites as efficient and stable phosphors for high-performance white light emitting diodes and other optoelectronic applications.

3.
Bioresour Technol ; 244(Pt 1): 345-352, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28780269

RESUMO

The removal rate and degradation pathway of Sulfamethoxazole (SMX) in bioelectrochemical system (BES) and the elimination dynamics of SMX in a BES driven by stacked constructed wetland-coupled microbial fuel cells (CW-MFCs) were investigated. The results found that SMX (30mgL-1) was rapidly degraded in the BES, and the SMX removal kinetics was simulated well by a first-order kinetic model (R2>0.93). Low current had no effect on the degradation products but enhanced the SMX removal rate. Biotransformation was the main pathway for the SMX elimination in the BES. The CW-MFCs supplied adequate and stable electricity (0.84-1.01V) to support the BES for rapid SMX degradation without additional energy inputs. The relative abundance of Methanosarcina (18.7%) and VadinCA11 (3.1%) increased with an increase in voltage up to 1.2V. However, the opposite was observed for Methanosaeta and Methanomassiliicoccus. The current in the BES influenced the methanogenic communities.


Assuntos
Fontes de Energia Bioelétrica , Sulfametoxazol , Biotransformação , Eletricidade , Áreas Alagadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA